Serology of DVI Phenotype Erythrocytes
| Anti-epD . | MoAb . | Erythrocyte . | |
|---|---|---|---|
| . | . | DVICcee (8512) . | DVIccEE (Vi) . |
| epD1 | REG-A | − | − |
| epD2 | P3x249 | − | − |
| epD3 | HD7 | + | + |
| epD4 | UCHD4 | + | + |
| epD5 | HAM-A | − | − |
| epD6/7 | RUM-1 | − | − |
| epD8 | p3×21211F1 | − | − |
| epD9 | BRAD-2 | + | + |
| Anti-epD . | MoAb . | Erythrocyte . | |
|---|---|---|---|
| . | . | DVICcee (8512) . | DVIccEE (Vi) . |
| epD1 | REG-A | − | − |
| epD2 | P3x249 | − | − |
| epD3 | HD7 | + | + |
| epD4 | UCHD4 | + | + |
| epD5 | HAM-A | − | − |
| epD6/7 | RUM-1 | − | − |
| epD8 | p3×21211F1 | − | − |
| epD9 | BRAD-2 | + | + |
Positive or negative reaction profiles of two of the erythrocytes derived from DVI phenotype individuals studied (DVICe donor no. 8512; and DVIcE Vi). MoAbs used with defined specificity are shown.